Free Delivery Over $100
|
|
|||
|
||||
OverviewThe fight against HIV/AIDS is, above all, an economic issue. The scale of the pandemic and the lack of funds needed to eradicate it require identifying key issues in field interventions and optimal economic policies to fund them. In developing countries, where the epidemic is reaching its peak, the magnitude of governmental and international interventions triggers major crowding-out effects on every other economic decision of those countries, and thus HIV/AIDS affects every aspect of social life. Economic policies alleviating crowding-out effects are thus paramount to foster the economic growth of developing countries and, in turn, their future welfare. Economic issues in the fight against HIV/AIDS are also a primary concern for developed countries, in charge not only of subsidising current treatment campaigns domestically but also of funding R&D in innovative treatments. Designing optimal incentives for public and private agencies to reduce the costs of available medicines, and to develop innovative treatments such as a therapeutic vaccine, is as important as drug delivery or any other field campaign to eventually eradicate the disease. Over two decades of practical implementation of economic policies and academic research have shown many pitfalls in current policies, and they have made it possible to identify previously missed issues. This book shall provide a recent and comprehensive coverage of those policies, and it shall analyse their economic efficiency as well as ways of improvement using state-of-the-art academic findings in Economics and Finance. The authors discuss in detail and provide new economic analyses on the following issues: The nation-wide and international economic consequences of the spread of the disease; Market incentives and disincentives to produce and to develop treatment technologies; The nature and optimality of economic policies devoted to fighting the disease in developing countries, as well as the enhancement of current policies through financial innovations. Full Product DetailsAuthor: Patrick LeoniPublisher: Nova Science Publishers Inc Imprint: Nova Science Publishers Inc Dimensions: Width: 26.00cm , Height: 1.50cm , Length: 18.00cm Weight: 0.416kg ISBN: 9781607415879ISBN 10: 1607415879 Pages: 196 Publication Date: 01 July 2010 Audience: Professional and scholarly , College/higher education , Professional & Vocational , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsPreface; General Introduction; Medical facts about HIV/AIDS; Specific Challenges in Developing Countries; Demography and economic growth; AIDS and private sector downfalls; Savings decline and banking instability; Crowding-out e ffects and public spending; AIDS-related expenditures and public budgets; Social Security and public organisms; Drugs patents and R&D incentives; Impediments to pharmaceutical R&D; Financial innovations and AIDS vaccines; Transition to innovative treatments; Current policies to fight HIV/AIDS; Index.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
